| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |